An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage.
Geneva: World Health Organization; 2018.
Top results in this bookTable of Contents
Hormonal Contraception and Post-menopausal Hormonal Therapy.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Lyon (FR): International Agency for Research on Cancer; 1999. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 72.)
Combined Estrogen–Progestogen Contraceptives and Combined Estrogen–Progestogen Menopausal Therapy.
Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 91.)
Terbutaline Pump for the Prevention of Preterm Birth [Internet].
Gaudet L, Singh K, Weeks L, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. (Comparative Effectiveness Reviews, No. 35.)
Oral Contraceptives & Breast Cancer.
Institute of Medicine (US) Committee on the Relationship Between Oral Contraceptives and Breast Cancer.
Washington (DC): National Academies Press (US); 1991.
Factors Affecting Contraceptive Use in Sub-Saharan Africa.
National Research Council (US) Working Group on Factors Affecting Contraceptive Use.
Washington (DC): National Academies Press (US); 1993.
Clinical Review Report: Mifepristone and misoprostol (Mifegymiso) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 May.
Selected Practice Recommendations for Contraceptive Use. 3rd edition.
Geneva: World Health Organization; 2016.
Clinical Applications of Mifepristone (RU 486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda.
Institute of Medicine (US) Committee on Antiprogestins: Assessing the Science; Donaldson MS, Dorflinger L, Brown SS, et al., editors.
Contraceptive Use and Controlled Fertility: Health Issues for Women and Children Background Papers.
National Research Council (US) Committee on Population; Parnell AM, editor.
Washington (DC): National Academies Press (US); 1989.
Clinical Review Report: Etonogestrel Extended-Release Subdermal Implant (Nexplanon): Merck Canada Inc. Indication: For the Prevention of Pregnancy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Dec.
Developing New Contraceptives: Obstacles and Opportunities.
National Research Council (US) and Institute of Medicine (US) Committee on Contraceptive Development; Mastroianni L Jr, Donaldson PJ, Kane TT, editors.
Washington (DC): National Academies Press (US); 1990.
Endotext [Internet].
Feingold KR, Ahmed SF, Anawalt B, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Pharmacoeconomic Report: Etonogestrel Extended-Release Subdermal Implant (Nexplanon): Merck Canada Inc. Indication: For the Prevention of Pregnancy [Internet].
Hormonal Contraceptive Methods for Women at High Risk of HIV and Living with HIV: 2014 Guidance Statement.
Geneva: World Health Organization; 2014.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Environmental Medicine: Integrating a Missing Element into Medical Education.
Institute of Medicine (US) Committee on Curriculum Development in Environmental Medicine; Pope AM, Rall DP, editors.
Washington (DC): National Academies Press (US); 1995.
Hormonally Active Agents in the Environment.
National Research Council (US) Committee on Hormonally Active Agents in the Environment.
Washington (DC): National Academies Press (US); 1999.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Carbetocin for the Prevention of Post-Partum Hemorrhage: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].
Chao YS, McCormack S.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jul 29.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on